"CBSA’s July Biobreakfast featured a panel discussion from three Colorado bioscience legends. The panel, moderated by new CBSA CEO Holli Baumunk, discussed a wide variety of issues including past mistakes and successes and recommendations to those in early stage companies. The panelists were:•Dr. William Freytag who was Chairman and CEO of Myogen when it was acquired by Gilead.
•Dr. Larry Gold who is CEO and Chairman at SomaLogic and has found two other companies including NeXstar, which merged with Gilead
•Patrick Mahaffy who is CEO of Clovis Oncology and previously served in the same role at Pharmion (sold to Celgene) and NeXstar"
Link to the Rocky Radar Recap
0 comments:
Post a Comment